Balancing Potency, Selectivity, and Developability in Peptide Therapeutics
Peptide therapeutics sit in a unique space between small molecules and biologics. They can achieve remarkable specificity while remaining relatively compact and chemically tunable. Over the years, I have learned that discovering a strong peptide binder is only the beginning. The real challenge is balance. In peptide drug discovery, we constantly weigh three critical factors: […]
The Future of Peptide Therapeutics in Cardiometabolic and Immunology Indications
Over the past two decades, I have watched peptide therapeutics move from a niche area of drug discovery into the mainstream. What excites me most today is not just the science, but the impact peptides are having in cardiometabolic and immunology diseases. These are areas where precision, safety, and long term treatment matter deeply. Peptides […]